Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
{{output}}
Background and aims: The reduced action of incretin hormones in type 2 diabetes (T2D) is mainly attributed to GIP insensitivity, but efficacy estimates of GIP and GLP-1 differ among studies, and the negligible effects of pharmaco... ...
